Robbie Singal, DrPH, is the Director of the Science and Technology Platform at Ariadne Labs. As Director, she oversees the teams in designing, testing, and implementing interventions developed at Ariadne Labs.
For over 15 years, Robbie has managed domestic and international research projects focused on HIV prevention and treatment, maternal and child health, and health services. At Fenway Health, she served as Project Director for two multi-site, federally-funded research networks where she was responsible for capacity building and managing the execution of behavioral, epidemiological, and clinical research studies.
Robbie received her BA from Northwestern University, MPH from University of North Carolina–Chapel Hill, and DrPH from Boston University.